Vascular Disease and Surgery

About

Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Articles

Percutaneous Transcatheter Closure of Interatrial Septal Defect in Adults - A Review

Citation:

Interventional Cardiology 2011;6(2):173–6

Management of the Asymptomatic Diabetic Patient with Evidence of Ischemia

Citation:

US Cardiology 2010; 7(1):76–80

The Surgeon's Role in Resynchronization Therapy

Citation:

US Cardiology 2008;5(1):70–1

Management of Haemostasis with Combined Use of Vascular Closure Devices and Bivalirudin - A Review

Citation:

Interventional Cardiology 2011;6(2):177–81